Home Prices on a Steady Track

By Susanne Dwyer

Home prices again appreciated nationally quarter-over-quarter, rising 0.9 percent, according to the Clear Capital Home Data Index™ (HDI™), a monthly report. Appreciation was highest in the West, where prices climbed 1.2 percent quarter-over-quarter.

Regionally:

Midwest
Growth quarter-over-quarter in the region came in at 0.9 percent, with prices in Detroit, Mich., appreciating at a 1.72 percent rate; prices in Dayton, Ohio, appreciating at a 1.28 percent rate; and prices in Columbus and Cleveland, Ohio, appreciating at a 1.24 percent rate.

Northeast
Growth quarter-over-quarter in the region came in at 1.1 percent, with prices in Providence, R.I., appreciating at a 1.51 percent rate; prices in New York, N.Y., appreciating at a 1.24 percent rate; and prices in Philadelphia and Pittsburgh, Pa., appreciating at a 0.43 percent rate.

South
Growth quarter-over-quarter in the region came in at 0.7 percent, with prices in Memphis, Tenn., appreciating at 1.75 percent; prices in Tampa, Fla. appreciating at 1.38 percent; and prices in New Orleans, La., appreciating at 1.29 percent.

West
Growth quarter-over-quarter in the region came in at 1.2 percent, with prices in San Jose, Calif., appreciating at 2.28 percent; prices in Las Vegas, Nev., appreciating at 2.01 percent; and prices in Seattle, Wash., appreciating at 1.51 percent.

Source: Clear Capital

For the latest real estate news and trends, bookmark RISMedia.com.

The post Home Prices on a Steady Track appeared first on RISMedia.

…read more

From:: Finance and Economy

Regional Spotlight: California Home Prices Close Year on High Note

By Susanne Dwyer

Amid the lowest housing inventory levels in more than 13 years, existing-home sales in California still eked out a year-over-year gain, while the median sales price posted a solid annual increase, according to the California Association of REALTORS® (C.A.R.).

Closed escrow sales of existing, single-family detached homes in California totaled a seasonally adjusted annualized rate of 420,960 units in December, according to information collected by C.A.R. from more than 90 local REALTOR® associations and MLSs statewide. The statewide sales figure represents what would be the total number of homes sold during 2017 if sales maintained the December pace throughout the year. It is adjusted to account for seasonal factors that typically influence home sales. The December sales figure was down 4.4 percent from the 440,340 level in November and up 1.4 percent compared with home sales in December 2016 of a revised 415,280.

For 2017 as a whole, a preliminary 423,760 homes closed escrow in California, up 1.4 percent from 2016’s pace of 417,720. After a strong first quarter start to 2017, sales momentum lost steam throughout the remainder of the year, and year-to-date sales growth declined steadily to hit the lowest level at the end of the year.

“A severe shortage of homes for sale continues to push up home prices and erode affordability, which in turn is subduing home sales,” says C.A.R. President Steve White. “What’s more, with the passage of the tax reform bill that makes home-buying less attractive, homeownership costs will increase for many, which could reduce the desire and demand for buying a home.”

The statewide median price continued to grow at a strong pace over last year, and remained above the $500,000 mark for the 10th straight month. The $549,560 December median price was 0.5 percent higher than November’s $546,820 and 7.6 percent higher than the revised $510,560 recorded in December 2016. The year-over-year price gain has been growing at or above 7 percent for six of the past seven months.

“California’s housing market turned in a respectable performance throughout 2017, with home sales increasing 1.4 percent and the median price climbing 6.9 percent for the year as a whole to reach $537,860 in 2017,” says C.A.R. Senior Vice President and Chief Economist Leslie Appleton-Young. “Looking ahead, the market will remain solid, but both sales and prices will be impacted by inventory shortages, impending interest rate hikes, and general economic factors, including the effects of tax reform.”

Other key points from C.A.R.’s December 2017 resale housing report include:

  • All of the major regions posted year-over-year sales declines, with sales in the Los Angeles metro region dropping 7.1 percent, sales in the Inland Empire decreasing 3.5 percent, and sales in the San Francisco Bay Area dipping 0.3 percent from last year.
  • Sales dropped in five of six counties in the Southern California region, with both Ventura and Orange counties decreasing by double digits. A supply shortage and affordability were likely factors in the decline. Sales in Los Angeles, San Diego and Riverside also dropped moderately when compared to last year, while sales in …read more

    From:: Real Estate News

Cerus shares rise on positive late-stage results for anemia therapy

Cerus Corp. shares rose 17.6% in Wednesday trade after the company said a late-stage clinical trial evaluating the company’s Intercept treatment for chronic anemia in patients with the inherited blood disorder thalassemia had positive results. In the phase 3 trial, which enrolled 86 patients, individuals with Intercept-treated red blood cells met the trial’s primary efficacy and safety endpoints, the company said. The company plans to file for commercialization in Europe in the second half of this year. Cerus shares have surged 77.4% over the last three months, compared with a 10.5% rise in the S&P 500 and a 11.8% rise in the Dow Jones Industrial Average .

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

EA stock falls after BioWare unit reportedly delays ‘Anthem’

A unit of Electronic Arts Inc. has pushed the release of one of its key gaming titles into early 2019, several months behind its scheduled release this year, according to the gaming blog Kotaku. EA stock is down 2.8% to $114.44 in afternoon trading Wednesday. The stock was trading steadily until the report hit the web at 1:30 p.m eastern time. Kotaku, citing unnamed sources, reported that EA’s BioWare unit has pushed back the release of “Anthem,” which the company announced in 2017. “All else equal, this likely wouldn’t have a massive impact to estimates; it raises further concerns about the production of the game if it gets pushed a second time,” wrote KeyBanc analyst Evan Wingren in a note to clients. “These concerns are likely to be amplified given the recent execution concerns. We currently model 9M units for the game.” EA will not allow BioWare to delay the release beyond March 2019, when the company’s fiscal year closes, the report said. EA did not immediately respond to a request for comment. EA stock is up 43% in the past year, as the S&P 500 index rose 25%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Campbell Soup to end Toronto manufacturing as part of cost-savings program

Campbell Soup Co. said Wednesday it is planning to close a manufacturing plant in Toronto and move its Canadian headquarters and commercial operations to a new location in the Greater Toronto Area. The food company said the move is part of a previously announced cost saving program that has already generated $345 million in annual savings. “Several factors have resulted in excess capacity in Campbell’s North American thermal supply chain network, including significant productivity improvements and volume declines of canned soup in North America,” said the company. Canadian production will be integrated into the U.S. manufacturing network. The company said 380 jobs out of 600 will be affected. Campbell currently has about 18,500 employees worldwide. Shares were down about 1% Wednesday, and have fallen 26% in the last 12 months, while the S&P 500 has gained 25%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Brazil’s PagSeguro Digital’s stock soars 34% above the IPO price to pace NYSE gainers

The newly minted shares of Brazil-based financial technology company PagSeguro Ditigal Ltd. soared 34% above their initial public offering price in afternoon trade Wednesday, enough to make them the biggest percentage gainer listed on New York Stock Exchange. The stock’s first trade was at $28.20 at 10:53 a.m. ET, which was 31% above the IPO price of $21.50. The stock has traded within a range of $28.00 to $29.25 since the open. The company raised $1.09 billion by offering 50.9 million shares to the public, while selling shareholder Universo Online S.A. sold 54.5 million shares to raise $1.17 billion. The company has gone public at a time that the Renaissance IPO ETF has gained 5.1% over the past three months, while the S&P 500 has run up 10.5%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Gold jumps 1.5% to highest finish in over a year

Gold prices rallied Wednesday to their highest finish in more than a year as the ICE U.S. Dollar Index dropped nearly 1% to its lowest level since late 2014–boosting demand for the precious metal, which is traded in the greenback. February gold rose $19.60, or 1.5%, to settle at $1,356.30 an ounce. That was the highest finish for a most-active futures contract since Aug. 18, 2016, according to FactSet data.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Menlo Therapeutics upsizes planned IPO and raises price range

Biotech Menlo Therapeutics Inc. has increased the size of its planned initial public offering and raised the price range, according to a regulatory filing. The company is now planning to offer 6.5 million shares priced at $16 to $17, to raise $107 million at the midpoint of the range. That’s up from a previous plan to offer 5.7 million shares at $14 to $16 each. The deal is expected to price later Wednesday, according to data firm Ipreo. The company has applied to list on Nasdaq under the ticker symbol “MNLO.” Jefferies, Piper Jaffray and Guggenheim are lead managers on the deal, with JMP Securities acting as co-manager. Menlo is a late-stage biotech focused on treatments for pruritus, or itch, in skin conditions including atopic dermatitis, psoriasis and others.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

GE’s stock tumbles toward biggest post-earnings decline in nearly 5 years

General Electric Co.’s stock tumbled 3.1% in afternoon trade Wednesday, putting it on track to suffer the biggest one-day post-earnings decline since first-quarter 2013 results were reported on April 19, 2013. On the day of the past 20 quarterly reports, the stock had declined 11 times, by an average of 1.7%. In comparison, the stock rose the day after nine of the past 20 quarterly reports by an average of 2.4%. The stock is now on track to decline after eight of the past nine quarterly reports. Earlier, GE reported fourth-quarter results that missed expectations, and disclosed an investigation by the Securities and Exchange Commission into its accounting processes. CFRA analyst Jim Corridore reiterated his hold rating on GE, saying the company needs to hit 2018 targets on cost cuts, asset sales and improved earnings and cash flow before the rating can change. “We will look for progress before becoming more positive,” Corridore said. GE shares have plummeted 45% over the past year, while the Dow Jones Industrial Average has climbed 31%.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News

Former US gymnastics team Doctor Larry Nassar sentenced to up to 175 years for sexual abuse

Dr. Lawrence Nassar, the former doctor for the U.S. gymnastics team, was sentenced to 40 to 175 years in prison by Michigan Judge Rosemarie Aquilina on Wednesday, after a seven-day hearing that allowed more than 150 women give public testimony on how he sexually abused them. Nassar, who is already serving a 60-year sentence for child pornography, was told by the judge: “I just signed your death warrant.” Aquilina took the unusual step of opening her courtroom to all the victims who wanted to directly address Nassar and ordered him to listen when he pleaded to make it stop. The women who were abused include Olympians Simone Biles, Gabby Douglas and Aly Raisman.

Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.

…read more

From:: Stock Market News